At the end of January 2020, the World Health Organization (WHO) shook the World to a standstill, as they had announced the novel coronavirus 2019 (SARS-Co-V-2) or COVID-19 as the "*public enemy number 1*". Emergency medical practitioners all over the World, have been on the frontlines of this modern-day crusade against the COVID-19 \[[@bb0005],[@bb0010]\]. A variety of attempts at eradicating this illness have failed and emergency practitioners are confronted every day with these critically ill patients. In many instances, despite of best medical care, the prognosis is dismal \[[@bb0015]\]. COVID-19 pneumonia is one particular concern, that those working on the frontlines of this pandemic have. At our institution, every single day dozens of patients are seen with this clinical condition and many of them end up in our COVID-19 intensive care unit.

Various therapeutic strategies in the treatment of COVID-19 pneumonia aim to alleviate the end-result of this infection. In Western medicine, a variety of antivirals have been tried, controversial drugs (i.e., hydroxychloroquine), antibiotics, vitamins, and in extreme cases, assisted mechanical ventilation, efficiency. In the emergency department (ED), attempts at stabilizing the oxygenation of these patients are attempted. Indeed, those patients who require intubation with assisted mechanical ventilation, have reported survival rates below 20% \[[@bb0020]\]. Therefore, the addition of alternative therapeutic interventions seems a reasonable approach, in an attempt to mitigate the effects of this deadly pandemic.

The use of Traditional Chinese Medicine (TCM), with or without the aid of conventional Western medicine, has been widely praised in China, as the standard of care for COVID-19 patients \[[@bb0025]\]. The use of herbal formulations, in particular, gained an enormous amount of support. In China, the State Administration of Traditional Chinese Medicine, gathered proficient practitioners of TCM to create a treatment program. This group of practitioners used symptomatic herbal therapy, and reported their first cured patient on January 24, 2020, which led to a cascade effect. By January 27, 2020, the General Office of the National Health, Health Commission, and the office of the State Administration of TCM released an integrated treatment program to be implemented. Classical herbal formulas, such as *Yu Ping Feng San, Sang Ju Yin and Yin Qiao San*, were highly sought out for prevention and treatment of COVID-19 \[[@bb0030]\].

In this issue of *The American Journal of Emergency Medicine*, Sun and coworkers present an adept metanalysis supporting the clinical efficacy and safety of using TCM herbal prescriptions for the treatment of COVID-19 \[[@bb0035]\]. The article incorporates, in detail, the results from seven studies, with 681 participants utilizing TCM as a therapeutic course of treatment. The results are interesting and encouraging. However, we suggest that we recognize that these outcomes may have some intrinsic issues. For example, we are concerned that the depicted results reflect a steady state of illness, whereas in TCM, measures can vary depending on which herbal formulations are administered, and the stage or rate of infection in each patient. TCM methodology used to diagnose and treat any pathology heavily relies on the time of exposure for all ailments. Other limitations of this metanalysis include the many variables of patient demographics, different herbal preparations, and access to funding to purchase such preparations. The authors are transparent and need to be applauded for their data analysis. Indeed, they suggest the results gathered could be, in fact, fallible.

So, what are emergency clinicians to learn from such a study? First, the fact that there are alternative therapeutic interventions that may be useful in the treatment of COVID-19. Second, in countries such as China, TCM is an essential part of the armamentarium to treat these patients. In contrasts, TCM practitioners and herbalists across Western communities have been sitting on the sidelines. Maybe it is time to implement an integrative approach in caring for COVID19 patients.

A variety of clinical trials are being conducted in an effort to contain this pandemic. Some of them involve TCM therapeutic interventions. In all likelihood, emergency clinicians will be conducting some of these trials, as the emergency department remains the port of entry to many patients suffering with COVID-19 pneumonia to the healthcare system.
